Skip to main content
View Cart

Preclinical Landscape in Cancer Research

  • 1st Edition - March 29, 2025
  • Latest edition
  • Editors: Ranjita Shegokar, Yashwant Pathak
  • Language: English

Preclinical Cancer Landscape discusses the issues in preclinical-to-clinical translatability of molecularly targeted cancer therapies and the need to better align tumour biolog… Read more

Early spring sale

Nurture your knowledge

Grow your expertise with up to 25% off trusted resources.

Shop now

Description

Preclinical Cancer Landscape discusses the issues in preclinical-to-clinical translatability of molecularly targeted cancer therapies and the need to better align tumour biology in patients With a strong focus on the status, challenges, prospects and the need of robustness of preclinical cancer research, the book acknowledges that the bar for reproducibility in performing and presenting preclinical studies must be raised to facilitate a transparent discovery process that frequently and consistently leads to significant patient benefit. In 22 chapters this book describes the current status of preclinical research in multiple cancers. This book is a timely and valuable resource for health professionals, scientists and researchers, health practitioners, students, and all those who wish to broaden their knowledge in the allied field. " Preclinical landscape in cancer research " is written by experts in the field and informed with facts directly from manufacturers. Pharmaceutical scientists, medical researchers, biomedical engineers and clinical professionals will find this an essential reference.

Key features

  • Contains current studies of the preclinical research of 25 different cancer types
  • Provides essential information on the most recent developments in preclinical cancer research
  • Explains current technology and its applications of preclinical cancer research
  • Holds contributions from oncologists, biomedical engineers, pharmaceutical scientists and manufacturers

Readership

Researchers working across the biosciences in fields of oncology, pharmacology

Table of contents

1. Liver cancer: current status of preclinical research

2. Pancreatic cancer: current status of preclinical research

3. Heart cancer: current status of preclinical research

4. Bone cancer: current status of preclinical research

5. Spleen cancer: current status of preclinical research

6. ENT cancer: current status of preclinical research

7. Brain/CSN cancer: current status of preclinical research

8. Skin cancer: current status of preclinical research

9. Lung cancer: current status of preclinical research

10. Thorax cancer: current status of preclinical research

11. Thyroid cancer: current status of preclinical research

12. Kidney-adrenal cancer: current status of preclinical research

13. Urinary tracker cancer: current status of preclinical research

14. Breast cancer: current status of preclinical research

15. Blood cancer: current status of preclinical research

16. Prostate cancer: current status of preclinical research

17. Gynecologic cancer: current status of preclinical research

18. Stomach and intestinal cancer: current status of preclinical research

19. Plura and peritoneum cancer: current status of preclinical research

20. Ocular cancer: current status of preclinical research

21. Oral cancer: current status of preclinical research

22. Growth Inhibitory Effects of Unsaturated Linoleinic Acid with Conjugated Double Bonds for Colon Cancer Prevention

Product details

  • Edition: 1
  • Latest edition
  • Published: June 9, 2025
  • Language: English

About the editors

RS

Ranjita Shegokar

Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)

Affiliations and expertise
Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, Germany

YP

Yashwant Pathak

Yashwant Pathak, is Professor, Taneja College of Pharmacy, at the University of South Florida. Tampa, USA. His area of research is nanotechnology, drug delivery systems and nutraceuticals. He is also Adjunct Professor at Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.

Affiliations and expertise
Professor, Taneja College of Pharmacy, University of South Florida, Tampa FL 33612 and Adjunct Professor , Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia

View book on ScienceDirect

Read Preclinical Landscape in Cancer Research on ScienceDirect